Amphastar Pharmaceuticals Pre-Tax Profit Margin 2012-2024 | AMPH
Amphastar Pharmaceuticals pre-tax profit margin from 2012 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Amphastar Pharmaceuticals Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-09-30 |
$0.72B |
$0.19B |
25.86% |
| 2024-06-30 |
$0.71B |
$0.20B |
28.47% |
| 2024-03-31 |
$0.68B |
$0.19B |
27.47% |
| 2023-12-31 |
$0.65B |
$0.17B |
26.67% |
| 2023-09-30 |
$0.60B |
$0.17B |
28.57% |
| 2023-06-30 |
$0.54B |
$0.13B |
24.21% |
| 2023-03-31 |
$0.52B |
$0.12B |
23.36% |
| 2022-12-31 |
$0.50B |
$0.12B |
23.29% |
| 2022-09-30 |
$0.48B |
$0.10B |
21.07% |
| 2022-06-30 |
$0.48B |
$0.12B |
24.58% |
| 2022-03-31 |
$0.46B |
$0.11B |
23.74% |
| 2021-12-31 |
$0.44B |
$0.08B |
19.18% |
| 2021-09-30 |
$0.41B |
$0.05B |
12.11% |
| 2021-06-30 |
$0.38B |
$0.02B |
4.95% |
| 2021-03-31 |
$0.37B |
$0.00B |
0.82% |
| 2020-12-31 |
$0.35B |
$0.00B |
1.14% |
| 2020-09-30 |
$0.34B |
$0.01B |
3.56% |
| 2020-06-30 |
$0.33B |
$0.01B |
2.10% |
| 2020-03-31 |
$0.33B |
$0.07B |
21.41% |
| 2019-12-31 |
$0.32B |
$0.06B |
18.63% |
| 2019-09-30 |
$0.33B |
$0.06B |
18.24% |
| 2019-06-30 |
$0.33B |
$0.06B |
18.77% |
| 2019-03-31 |
$0.32B |
$-0.00B |
-1.26% |
| 2018-12-31 |
$0.30B |
$-0.01B |
-3.05% |
| 2018-09-30 |
$0.27B |
$-0.01B |
-4.15% |
| 2018-06-30 |
$0.25B |
$-0.02B |
-6.48% |
| 2018-03-31 |
$0.24B |
$-0.01B |
-3.73% |
| 2017-12-31 |
$0.24B |
$0.00B |
0.83% |
| 2017-09-30 |
$0.24B |
$-0.00B |
-0.82% |
| 2017-06-30 |
$0.25B |
$0.01B |
2.40% |
| 2017-03-31 |
$0.25B |
$0.01B |
5.14% |
| 2016-12-31 |
$0.26B |
$0.02B |
5.88% |
| 2016-09-30 |
$0.27B |
$0.03B |
11.19% |
| 2016-06-30 |
$0.27B |
$0.02B |
7.46% |
| 2016-03-31 |
$0.25B |
0 |
0.00% |
| 2015-12-31 |
$0.25B |
$-0.01B |
-3.97% |
| 2015-09-30 |
$0.23B |
$-0.03B |
-11.26% |
| 2015-06-30 |
$0.23B |
$-0.03B |
-13.22% |
| 2015-03-31 |
$0.22B |
$-0.02B |
-9.91% |
| 2014-12-31 |
$0.21B |
$-0.02B |
-8.53% |
| 2014-09-30 |
$0.21B |
$-0.01B |
-4.29% |
| 2014-06-30 |
$0.21B |
$-0.00B |
-0.48% |
| 2014-03-31 |
$0.22B |
$0.01B |
5.83% |
| 2013-12-31 |
$0.23B |
$0.02B |
7.39% |
| 2013-09-30 |
$0.23B |
$0.07B |
29.07% |
| 2013-06-30 |
$0.23B |
$0.12B |
54.67% |
| 2013-03-31 |
$0.21B |
$0.16B |
75.83% |
| 2012-12-31 |
$0.20B |
$0.20B |
100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.894B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
